Retroperitoneal Sarcoma — Trials

Retroperitoneal Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05174455	Niraparib for the Treatment of Leiomyosarcoma	withdrawn	Phase 2	0	David Liebner, MDOTHER	0	Sep 18, 2023	clinicaltrials
NCT05302570	Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS(PROTONS-RPS)	withdrawn	Phase 2	0	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Dec 15, 2022	clinicaltrials